1
|
Mulliken JB and Glowacki J: Hemangiomas
and vascular malformations in infants and children: a
classification based on endothelial characteristics. Plast Reconstr
Surg. 69:412–422. 1982. View Article : Google Scholar
|
2
|
Yang Y, Sun M, Hou R, et al: Preliminary
study of fibrin glue combined with pingyangmycin for the treatment
of venous malformations in the oral and maxillofacial region. J
Oral Maxillofac Surg. 66:2219–2225. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Liu XJ, Qin ZP and Tai MZ: Angiographic
classification and sclerotic therapy of maxillofacial cavernous
haemangiomas: a report of 204 cases. J Int Med Res. 37:1285–1292.
2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Luo Q and Zhao F: How to use bleomycin A5
for infantile maxillofacial haemangiomas: clinical evaluation of 82
consecutive cases. J Craniomaxillofac Surg. 39:482–486. 2011.
View Article : Google Scholar
|
5
|
Hou J, Wang M, Tang H, Wang Y and Huang H:
Pingyangmycin sclerotherapy for infantile hemangiomas in oral and
maxillofacial regions: an evaluation of 66 consecutive patients.
Int J Oral Maxillofac Surg. 40:1246–1251. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gong JH, Liu XJ, Li Y and Zhen YS:
Pingyangmycin downregulates the expression of EGFR and enhances the
effects of cetuximab on esophageal cancer cells and the xenograft
in athymic mice. Cancer Chemother Pharmacol. 69:1323–1332. 2012.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Chen P, Liu B and Hu M: The effect of
hydroxycamptothecin and pingyangmycin on human squamous cell
carcinoma of the tongue. Oncol Lett. 5:947–952. 2013.PubMed/NCBI
|
8
|
Martines F, Bentivegna D, Maira E, et al:
Cavernous haemangioma of the external auditory canal: clinical case
and review of the literature. Acta Otorhinolaryngol Ital. 32:54–57.
2012.PubMed/NCBI
|
9
|
Gu L, Huang DY, Fu CJ, et al:
Intralesional injection of Pingyangmycin plus corticosteroids may
be an effective treatment for cheilitis granulomatosa. Med
Hypotheses. 81:729–730. 2013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Yue H, Qian J, Elner VM, et al: Treatment
of orbital vascular malformations with intralesional injection of
pingyangmycin. Br J Ophthalmol. 97:739–745. 2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Mabeta P and Pepper MS: Inhibition of
hemangioma development in a syngeneic mouse model correlates with
bcl-2 suppression and the inhibition of Akt kinase activity.
Angiogenesis. 15:131–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Gordillo G, Fang H, Khanna S, Harper J,
Phillips G and Sen CK: Oral administration of blueberry inhibits
angiogenic tumor growth and enhances survival of mice with
endothelial cell neoplasm. Antioxid Redox Signal. 11:47–58. 2009.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Otsuki Y: Various methods of apoptosis
detection. Acta Histochem Cytochem. 33:235–241. 2000. View Article : Google Scholar
|
14
|
Tang J, Li J, Zeng G, et al: Antisense
oligonucleotide suppression of human IGF-1R inhibits the growth and
survival of in vitro cultured epithelial ovarian cancer cells. J
Ovarian Res. 6:712013. View Article : Google Scholar
|
15
|
Farivar TN, Najafipour R and Johari P:
Nano - drug delivery of apoptosis activator 2 to AGS cells by
liposomes conjugated with anti-TROP2 antibody. N Am J Med Sci.
4:582–585. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Hewitson TD, Bisucci T and Darby IA:
Histochemical localization of apoptosis with in situ labeling of
fragmented DNA. Methods Mol Biol. 326:227–234. 2006.PubMed/NCBI
|
17
|
Chang HY and Yang X: Proteases for cell
suicide: functions and regulation of caspases. Microbiol Mol Biol
Rev. 64:821–846. 2000. View Article : Google Scholar
|
18
|
Woo M, Hakem R, Soengas MS, et al:
Essential contribution of caspase 3/CPP32 to apoptosis and its
associated nuclear changes. Genes Dev. 12:806–819. 1998. View Article : Google Scholar : PubMed/NCBI
|
19
|
Takagi Y, Hattori I, Nozaki K, Ishikawa M
and Hashimoto N: DNA fragmentation in central nervous system
vascular malformations. Acta Neurochir (Wien). 142:987–994. 2000.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhang Y, Chong E and Herman B:
Age-associated increases in the activity of multiple caspases in
Fisher 344 rat organs. Exp Gerontol. 37:777–789. 2002. View Article : Google Scholar : PubMed/NCBI
|
21
|
Vanden Berghe T, Denecker G, Brouckaert G,
Vadimovisch Krysko D, D’Herde K and Vandenabeele P: More than one
way to die: methods to determine TNF-induced apoptosis and
necrosis. Methods Mol Med. 98:101–126. 2004.PubMed/NCBI
|
22
|
Piro LD: Apoptosis, Bcl-2 antisense, and
cancer therapy. Oncology (Williston Park). 18:5–10. 2004.PubMed/NCBI
|
23
|
Kalas W, Swiderek E, Switalska M, Wietrzyk
J, Rak J and Strzadala L: Thrombospondin-1 receptor mediates
autophagy of RAS-expressing cancer cells and triggers tumour growth
inhibition. Anticancer Res. 33:1429–1438. 2013.PubMed/NCBI
|
24
|
Adrain C, Murphy BM and Martin SJ:
Molecular ordering of the caspase activation cascade initiated by
the cytotoxic T lymphocyte/natural killer (CTL/NK) protease
granzyme B. J Biol Chem. 280:4663–4673. 2005. View Article : Google Scholar
|
25
|
Sarkars R, Mukherjee S and Roy M:
Targeting heat shock proteins by phenethyl isothiocyanate results
in cell-cycle arrest and apoptosis of human breast cancer cells.
Nutr Cancer. 65:480–493. 2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Frejlich E, Rudno-Rudzińska J, Janiszewski
K, et al: Caspases and their role in gastric cancer. Adv Clin Exp
Med. 22:593–602. 2013.
|